At a glance
ClinicalIndex Comparison RecordN/ACompleted· 221 enrolled
Drug / intervention
Life Completion +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Outlook: An Intervention to Improve Quality of Life in Serious Illness Study
In Brief
A clinical study evaluating Life Completion and Attention Control for Cancer and 3 related conditions. Completed, enrolled 221 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether discussions of life story, forgiveness, and future goals improve quality of life for patients with serious illness.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer, Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD), End Stage Renal Disease (ESRD)
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 2010
Enrollment StartJan 2011
Primary CompletionFeb 2014
Study CompletionApr 2014
TodayJul 2026
First PostedJan 7, 2010
Enrollment StartJan 1, 2011
Primary CompletionFeb 1, 2014
Study CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 16.5 years ago
Interventions
Life Completionother
Subjects discussed life review, issues of forgiveness and heritage and legacy.
Attention Controlother
Subjects listened to a non-guided relaxation CD